The transcriptional transactivator Tat selectively regulates viral splicing

Nucleic Acids Research

Volumn 38, Issue 4, 2009, Pages 1249-1260

  Jablonski, Joseph A ^a   Amelio, Antonio L ^b   Giacca, Mauro ^c   Caputi, Massimo ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; HTATSF1 PROTEIN, HUMAN; NEF PROTEIN; REV PROTEIN; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS-1; RNA POLYMERASE II; TCERG1 PROTEIN, HUMAN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN FUNCTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TRANSCRIPTION INITIATION; VIRUS GENOME; WESTERN BLOTTING; ALTERNATIVE RNA SPLICING; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ALTERNATIVE SPLICING; CELL LINE; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA POLYMERASE II; RNA SPLICE SITES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 77950357931     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp1105     Document Type: Article

References (41)

1. Berkhout, B., Silverman, R.H. and Jeang, K.T. (1989) Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell, 59, 273-282.
2. Cullen, B.R. (1998) HIV-1 auxiliary proteins: making connections in a dying cell. Cell, 93, 685-692.
3. Wei, P., Garber, M.E., Fang, S.M., Fischer, W.H. and Jones, K.A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell, 92, 451-462.
4. Zhou, M., Halanski, M.A., Radonovich, M.F., Kashanchi, F., Peng, J., Price, D.H. and Brady, J.N. (2000) Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol., 20, 5077-5086.
5. Isel, C. and Karn, J. (1999) Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. J. Mol. Biol., 290, 929-941.
6. Zhou, Q. and Sharp, P.A. (1996) Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science, 274, 605-610.
7. Fong, Y.W. and Zhou, Q. (2001) Stimulatory effect of splicing factors on transcriptional elongation. Nature, 414, 929-933.
8. Parada, C.A. and Roeder, R.G. (1999) A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription. EMBO J., 18, 3688-3701.
9. Smith, M.J., Kulkarni, S. and Pawson, T. (2004) FF domains of CA150 bind transcription and splicing factors through multiple weak interactions. Mol. Cell. Biol., 24, 9274-9285.
10. Sune, C. and Garcia-Blanco, M.A. (1999) Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner. Mol. Cell. Biol., 19, 4719-4728.
11. Carty, S.M., Goldstrohm, A.C., Sune, C., Garcia-Blanco, M.A. and Greenleaf, A.L. (2000) Protein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase II. Proc. Natl Acad. Sci. USA, 97, 9015-9020.
12. Sanchez-Alvarez, M., Goldstrohm, A.C., Garcia-Blanco, M.A. and Sune, C. (2006) Human transcription elongation factor CA150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its amino and carboxyl regions. Mol. Cell. Biol., 26, 4998-5014.
13. Bres, V., Gomes, N., Pickle, L. and Jones, K.A. (2005) A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat. Genes Develop., 19, 1211-1226.
14. Purcell, D.F.J. and Martin, M.A. (1993) Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication and infectivity. J. Virol., 67, 6365-6378.
15. Jablonski, J.A., Buratti, E., Stuani, C. and Caputi, M. (2008) The secondary structure of the human immunodeficiency virus type 1 transcript modulates viral splicing and infectivity. J. Virol., 82, 8038-8050.
16. Stoltzfus, C.M. and Madsen, J.M. (2006) Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing. Curr. HIV Res., 4, 43-55.
17. Schaub, M.C., Lopez, S.R. and Caputi, M. (2007) Members of the heterogeneous nuclear ribonucleoprotein H family activate splicing of an HIV-1 splicing substrate by promoting formation of ATP-dependent spliceosomal complexes. J. Biol. Chem., 282, 13617-13626.
18. McLaren, M., Marsh, K. and Cochrane, A. (2008) Modulating HIV-1 RNA processing and utilization. Front Biosci., 13, 5693-5707.
19. Graveley, B.R. (2000) Sorting out the complexity of SR protein functions. RNA, 6, 1197-1211.
20. Das, R., Yu, J., Zhang, Z., Gygi, M.P., Krainer, A.R., Gygi, S.P. and Reed, R. (2007) SR proteins function in coupling RNAP II transcription to pre-mRNA splicing. Mol. Cell, 26, 867-881.
21. Lin, S., Coutinho-Mansfield, G., Wang, D., Pandit, S. and Fu, X.D. (2008) The splicing factor SC35 has an active role in transcriptional elongation. Nature Struct. Mol. Biol., 15, 819-826.
22. Fong, N. and Bentley, D.L. (2001) Capping, splicing, and 3′ processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD. Genes Develop., 15, 1783-1795.
23. Hicks, M.J., Yang, C.R., Kotlajich, M.V. and Hertel, K.J. (2006) Linking splicing to Pol II transcription stabilizes pre-mRNAs and influences splicing patterns. PLoS Biol., 4, e147.
24. Kwek, K.Y., Murphy, S., Furger, A., Thomas, B., O'Gorman, W., Kimura, H., Proudfoot, N.J. and Akoulitchev, A. (2002) U1 snRNA associates with TFIIH and regulates transcriptional initiation. Nature Struct. Biol., 9, 800-805.
25. Damgaard, C.K., Kahns, S., Lykke-Andersen, S., Nielsen, A.L., Jensen, T.H. and Kjems, J. (2008) A 5′ splice site enhances the recruitment of basal transcription initiation factors in vivo. Mol. Cell, 29, 271-278.
26. Batsche, E., Yaniv, M. and Muchardt, C. (2006) The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nature Struct. Mol. Biol., 13, 22-29.
27. de la Mata, M., Alonso, C.R., Kadener, S., Fededa, J.P., Blaustein, M., Pelisch, F., Cramer, P., Bentley, D. and Kornblihtt, A.R. (2003) A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell, 12, 525-532.
28. Bentley, D.L. (2005) Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. Curr. Opin. Cell Biol., 17, 251-256.
29. Amendt, B.A., Hesslein, D., Chang, L.J. and Stoltzfus, C.M. (1994) Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell. Biol., 14, 3960-3970.
30. Caputi, M., Freund, M., Kammler, S., Asang, C. and Schaal, H. (2004) A bidirectional SF2/ASF-and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. J. Virol., 78, 6517-6526.
31. Caputi, M., Mayeda, A., Krainer, A.R. and Zahler, A.M. (1999) hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J., 18, 4060-4067.
32. Zahler, A.M., Damgaard, C.K., Kjems, J. and Caputi, M. (2004) SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing. J. Biol. Chem., 279, 10077-10084.
33. Kammler, S., Cordula, L., Freund, M., Krummheuer, J., Seidel, K., Tange, T.O., Mette, K.L., Kjems, J., Scheid, A. and Schaal, H. (2001) The sequence complementarity between HIV-1 5′ splice site SD4 and U1 snRNA determines the steady-level of an unstable env pre-mRNA. RNA, 7, 421-434.
34. Sadaie, M.R., Benter, T. and Wong-Staal, F. (1988) Site-directed mutagenesis of two trans-regulatory genes (tat-III, trs) of HIV-1. Science, 239, 910-913.
35. Graveley, B.R., Hertel, K.J. and Maniatis, T. (1998) A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J., 17, 6747-6756.
36. Berkhout, B. and Jeang, K.T. (1992) Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol., 66, 139-149.
37. Misteli, T. and Spector, D.L. (1999) RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo. Mol. Cell, 3, 697-705.
38. Hirose, Y., Tacke, R. and Manley, J.L. (1999) Phosphorylated RNA polymerase II stimulates pre-mRNA splicing. Genes Develop., 13, 1234-1239.
39. Kornblihtt, A.R. (2005) Promoter usage and alternative splicing. Curr. Opin. Cell Biol., 17, 262-268.
40. Fong, Y.W. and Zhou, Q. (2000) Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter. Mol. Cell. Biol., 20, 5897-5907.
41. Lu, X., Heimer, J., Rekosh, D. and Hammarskjold, M.L. (1990) U1 small nuclear RNA plays a direct role in the formation of a rev-regulated immunodeficiency virus env mRNA that remains unspliced. Proc. Natl Acad. Sci. USA, 87, 7598-7602.